Ken Fisher's ANAB Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 56,596 shares of AnaptysBio, Inc. (ANAB) worth $3.14 M, representing 0.00% of the portfolio. First purchased in 2021-Q3, this medium-term investment has been held for 19 quarters.
Based on 13F filings, Ken Fisher has maintained a strategic position in ANAB, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2021, adding 13,402 shares. Largest reduction occurred in Q1 2023, reducing 6,896 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's AnaptysBio (ANAB) Holding Value Over Time
Track share changes against reported price movement
Quarterly AnaptysBio (ANAB) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +32 | Add 0.06% | 56,596 | $55.46 |
| Q4 2025 | -2,314 | Reduce 3.93% | 56,564 | $48.48 |
| Q3 2025 | -21 | Reduce 0.04% | 58,878 | $30.62 |
| Q2 2025 | +21 | Add 0.04% | 58,899 | $22.20 |
| Q4 2024 | -3,070 | Reduce 4.96% | 58,878 | $13.24 |
| Q3 2024 | -3,044 | Reduce 4.68% | 61,948 | $33.50 |
| Q2 2024 | -5,662 | Reduce 8.01% | 64,992 | $25.06 |
| Q1 2024 | -500 | Reduce 0.70% | 70,654 | $22.52 |
| Q4 2023 | +500 | Add 0.71% | 71,154 | $21.42 |
| Q1 2023 | -6,896 | Reduce 8.89% | 70,654 | $21.76 |
| Q3 2022 | +10 | Add 0.01% | 77,550 | $25.51 |
| Q2 2022 | +9,651 | Add 14.22% | 77,540 | $20.30 |
| Q1 2022 | +8,468 | Add 14.25% | 67,889 | $24.75 |
| Q4 2021 | +13,402 | Add 29.12% | 59,421 | $34.75 |
| Q3 2021 | +46,019 | New Buy | 46,019 | $27.12 |
Ken Fisher's AnaptysBio Investment FAQs
Ken Fisher first purchased AnaptysBio, Inc. (ANAB) in Q3 2021, acquiring 46,019 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held AnaptysBio, Inc. (ANAB) for 19 quarters since Q3 2021.
Ken Fisher's largest addition to AnaptysBio, Inc. (ANAB) was in Q3 2021, adding 46,019 shares worth $1.25 M.
According to the latest 13F filing for Q1 2026, Ken Fisher's firm, Fisher Asset Management, LLC, owns 56,596 shares of AnaptysBio, Inc. (ANAB), valued at approximately $3.14 M.
As of the Q1 2026 filing, AnaptysBio, Inc. (ANAB) represents approximately 0.00% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in AnaptysBio, Inc. (ANAB) was 77,550 shares, as reported at the end of Q3 2022.